The opposing effects of n−3 and n−6 fatty acids

Marszalek, 2005, Docosahexaenoic acid, fatty acid–interacting proteins, and neuronal function: breastmilk and fish are good for you, Annu Rev Cell Dev Biol, 21, 633, 10.1146/annurev.cellbio.21.122303.120624

Bozza, 2005, Mechanisms of leukocyte lipid body formation and function in inflammation, Mem Inst Oswaldo Cruz, 100, 113, 10.1590/S0074-02762005000900020

Bandeira-Melo, 2002, The cellular biology of eosinophil eicosanoid formation and function, J Allergy Clin Immunol, 109, 393, 10.1067/mai.2002.121529

Contreras, 2002, Recent studies on interactions between n−3 and n−6 polyunsaturated fatty acids in brain and other tissues, Curr Opin Lipidol, 13, 267, 10.1097/00041433-200206000-00006

Leventhal, 2004, Suppression of macrophage eicosanoid synthesis by atherogenic lipoproteins is profoundly affected by cholesterol-fatty acyl esterification and the Niemann-Pick C pathway of lipid trafficking, J Biol Chem, 279, 8084, 10.1074/jbc.M310672200

Arita, 2005, Stereochemical assignment, antiinflammatory properties, and receptor for the omega−3 lipid mediator resolvin E1, J Exp Med, 201, 713, 10.1084/jem.20042031

Prescott, 2005, Fish oil fix, Nat Med, 11, 596, 10.1038/nm0605-596

Serhan, 2007, Mediator lipidomics: search algorithms for eicosanoids, resolvins, and protectins, Meth Enzymol, 432, 275, 10.1016/S0076-6879(07)32012-0

Bagga, 2003, Differential effects of prostaglandin derived from omega−6 and omega−3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion, Proc Natl Acad Sci USA, 100, 1751, 10.1073/pnas.0334211100

Robinson, 2006, Antiatherosclerotic and antithrombotic effects of omega−3 fatty acids, Am J Cardiol, 98, 39i, 10.1016/j.amjcard.2005.12.026

Li, 1997, Differential effects of various eicosanoids on the production or prevention of arrhythmias in cultured neonatal rat cardiac myocytes, Prostaglandins, 54, 511, 10.1016/S0090-6980(97)00122-6

Levy, 2001, Lipid mediator class switching during acute inflammation: signals in resolution, Nat Immunol, 2, 612, 10.1038/89759

Vachier, 2002, Endogenous anti-inflammatory mediators from arachidonate in human neutrophils, Biochem Biophys Res Commun, 290, 219, 10.1006/bbrc.2001.6155

Gewirtz, 2002, Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis, J Immunol, 168, 5260, 10.4049/jimmunol.168.10.5260

Serhan, 2003, Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators, J Immunol, 171, 6856, 10.4049/jimmunol.171.12.6856

Weber, 1986, The conversion of dietary eicosapentaenoic acid to prostanoids and leukotrienes in man, Prog Lipid Res, 25, 273, 10.1016/0163-7827(86)90056-1

Calder, 2006, Polyunsaturated fatty acids and inflammation, Prostag Leukot Essent Fatty Acids, 75, 197, 10.1016/j.plefa.2006.05.012

Fogh, 1989, Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions, J Invest Dermatol, 92, 837, 10.1111/1523-1747.ep12696858

Schwab, 2007, Resolvin E1 and protectin D1 activate inflammation-resolution programmes, Nature, 447, 869, 10.1038/nature05877

Serhan, 2000, Anti-microinflammatory lipid signals generated from dietary N−3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N−3 PUFA therapeutic actions, J Physiol Pharmacol, 51, 643

Serhan, 2000, Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega−3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing, J Exp Med, 192, 1197, 10.1084/jem.192.8.1197

Serhan, 2002, Resolvins: a family of bioactive products of omega−3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals, J Exp Med, 196, 1025, 10.1084/jem.20020760

Hong, 2003, Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation, J Biol Chem, 278, 14677, 10.1074/jbc.M300218200

Marcheselli, 2003, Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression, J Biol Chem, 278, 43807, 10.1074/jbc.M305841200

Mukherjee, 2004, Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress, Proc Natl Acad Sci USA, 101, 8491, 10.1073/pnas.0402531101

Healy, 2000, Effect of low-to-moderate amounts of dietary fish oil on neutrophil lipid composition and function, Lipids, 35, 763, 10.1007/s11745-000-0583-1

Lee, 1985, Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function, New Engl J Med, 312, 1217, 10.1056/NEJM198505093121903

Endres, 1989, The effect of dietary supplementation with n−3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells, New Engl J Med, 320, 265, 10.1056/NEJM198902023200501

Caughey, 1996, The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n−3 fatty acids from vegetable oil or fish oil, Am J Clin Nutr, 63, 116, 10.1093/ajcn/63.1.116

Meydani, 1993, Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived N−3 fatty acid enrichment, J Clin Invest, 92, 105, 10.1172/JCI116537

Trebble, 2003, Prostaglandin E2 production and T cell function after fish-oil supplementation: response to antioxidant cosupplementation, Am J Clin Nutr, 78, 376, 10.1093/ajcn/78.3.376

Sperling, 1993, Dietary omega−3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils, J Clin Invest, 91, 651, 10.1172/JCI116245

von, 1993, n−3 fatty acids and cysteinyl-leukotriene formation in humans in vitro, ex vivo, and in vivo, J Lab Clin Med, 121, 302

Niu, 2004, Reduced G protein-coupled signaling efficiency in retinal rod outer segments in response to n−3 fatty acid deficiency, J Biol Chem, 279, 31098, 10.1074/jbc.M404376200

Pitman, 2005, Role of cholesterol and polyunsaturated chains in lipid–protein interactions: molecular dynamics simulation of rhodopsin in a realistic membrane environment, J Am Chem Soc, 127, 4576, 10.1021/ja042715y

Soubias, 2005, Probing specific lipid–protein interaction by saturation transfer difference NMR spectroscopy, J Am Chem Soc, 127, 13110, 10.1021/ja0538942

Grossfield, 2006, A role for direct interactions in the modulation of rhodopsin by omega−3 polyunsaturated lipids, Proc Natl Acad Sci USA, 103, 4888, 10.1073/pnas.0508352103

Sugimoto, 2007, Prostaglandin E receptors, J Biol Chem, 282, 11613, 10.1074/jbc.R600038200

Lundeen, 2006, Leukotriene B4 receptors BLT1 and BLT2: expression and function in human and murine mast cells, J Immunol, 177, 3439, 10.4049/jimmunol.177.5.3439

Serhan, 2005, Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution, Prostag Leukot Essent Fatty Acids, 73, 141, 10.1016/j.plefa.2005.05.002

Feller, 2005, Properties of docosahexaenoic-acid-containing lipids and their influence on the function of rhodopsin, Curr Opin Struct Biol, 15, 416, 10.1016/j.sbi.2005.07.002

Eldho, 2003, Polyunsaturated docosahexaenoic vs docosapentaenoic acid-differences in lipid matrix properties from the loss of one double bond, J Am Chem Soc, 125, 6409, 10.1021/ja029029o

Rajamoorthi, 2005, Packing and viscoelasticity of polyunsaturated omega−3 and omega−6 lipid bilayers as seen by (2)H NMR and X-ray diffraction, J Am Chem Soc, 127, 1576, 10.1021/ja046453b

Simons, 2004, Model systems, lipid rafts, and cell membranes, Annu Rev Biophys Biomol Struct, 33, 269, 10.1146/annurev.biophys.32.110601.141803

Akbar, 2005, Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival, Proc Natl Acad Sci USA, 102, 10858, 10.1073/pnas.0502903102

Stulnig, 2001, Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition, J Biol Chem, 276, 37335, 10.1074/jbc.M106193200

Li, 2006, Polyunsaturated eicosapentaenoic acid changes lipid composition in lipid rafts, Eur J Nutr, 45, 144, 10.1007/s00394-005-0574-7

Diaz, 2002, The mechanism of docosahexaenoic acid-induced phospholipase D activation in human lymphocytes involves exclusion of the enzyme from lipid rafts, J Biol Chem, 277, 39368, 10.1074/jbc.M202376200

Fan, 2003, Dietary (n−3) polyunsaturated fatty acids remodel mouse T-cell lipid rafts, J Nutr, 133, 1913, 10.1093/jn/133.6.1913

Schley, 2007, (n−3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells, J Nutr, 137, 548, 10.1093/jn/137.3.548

Chawla, 2001, Nuclear receptors and lipid physiology: opening the X-files, Science, 294, 1866, 10.1126/science.294.5548.1866

Ghosh, 2002, Missing pieces in the NF-kappaB puzzle, Cell, 109, S81, 10.1016/S0092-8674(02)00703-1

Lo, 1999, Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity, J Surg Res, 82, 216, 10.1006/jsre.1998.5524

Novak, 2003, NF-kappa B inhibition by omega−3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription, Am J Physiol Lung Cell Mol Physiol, 284, L84, 10.1152/ajplung.00077.2002

Zhao, 2004, Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation, J Am Coll Nutr, 23, 71, 10.1080/07315724.2004.10719345

Hudert, 2006, Transgenic mice rich in endogenous omega−3 fatty acids are protected from colitis, Proc Natl Acad Sci USA, 103, 11276, 10.1073/pnas.0601280103

Weldon, 2007, Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid, J Nutr Biochem, 18, 250, 10.1016/j.jnutbio.2006.04.003

Node, 1999, Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids, Science, 285, 1276, 10.1126/science.285.5431.1276

Spiecker, 2005, Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids, Arch Biochem Biophys, 433, 413, 10.1016/j.abb.2004.10.009

Lepley, 1998, 5-Lipoxygenase compartmentalization in granulocytic cells is modulated by an internal bipartite nuclear localizing sequence and nuclear factor kappa B complex formation, Arch Biochem Biophys, 356, 71, 10.1006/abbi.1998.0744

Soberman, 2003, The organization and consequences of eicosanoid signaling, J Clin Invest, 111, 1107, 10.1172/JCI200318338

Schmitz, 2005, Transcriptional regulatory networks in lipid metabolism control ABCA1 expression, Biochim Biophys Acta, 1735, 1, 10.1016/j.bbalip.2005.04.004

Li, 2004, Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma, J Clin Invest, 114, 1564, 10.1172/JCI18730

Jump, 1999, Regulation of gene expression by dietary fat, Annu Rev Nutr, 19, 63, 10.1146/annurev.nutr.19.1.63

Couet, 1997, Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults, Int J Obes Relat Metab Disord, 21, 637, 10.1038/sj.ijo.0800451

Power, 1997, Dietary fatty acids influence the activity and metabolic control of mitochondrial carnitine palmitoyltransferase I in rat heart and skeletal muscle, J Nutr, 127, 2142, 10.1093/jn/127.11.2142

Hu, 1999, Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women, Am J Clin Nutr, 69, 890, 10.1093/ajcn/69.5.890

Mori, 1999, Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects, Am J Clin Nutr, 70, 817, 10.1093/ajcn/70.5.817

Krey, 1997, Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay, Mol Endocrinol, 11, 779, 10.1210/me.11.6.779

Kliewer, 1995, A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation, Cell, 83, 813, 10.1016/0092-8674(95)90194-9

Li, 2005, EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism, Kidney Int, 67, 867, 10.1111/j.1523-1755.2005.00151.x

Poynter, 1998, Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging, J Biol Chem, 273, 32833, 10.1074/jbc.273.49.32833

Ricote, 1999, The peroxisome proliferator-activated receptor(PPARgamma) as a regulator of monocyte/macrophage function, J Leukoc Biol, 66, 733, 10.1002/jlb.66.5.733

de Urquiza, 2000, Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain, Science, 290, 2140, 10.1126/science.290.5499.2140

Lengqvist, 2004, Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain, Mol Cell Proteomics, 3, 692, 10.1074/mcp.M400003-MCP200

Fan, 2003, Chemopreventive n−3 fatty acids activate RXRalpha in colonocytes, Carcinogenesis, 24, 1541, 10.1093/carcin/bgg110

Shimano, 2001, Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes, Prog Lipid Res, 40, 439, 10.1016/S0163-7827(01)00010-8

Ecker, 2007, Isomer specific effects of Conjugated Linoleic Acid on macrophage ABCG1 transcription by a SREBP-1c dependent mechanism, Biochem Biophys Res Commun, 352, 805, 10.1016/j.bbrc.2006.11.087

Horton, 2002, SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver, J Clin Invest, 109, 1125, 10.1172/JCI0215593

Dobrosotskaya, 2002, Regulation of SREBP processing and membrane lipid production by phospholipids in Drosophila, Science, 296, 879, 10.1126/science.1071124

Kurzchalia, 2003, Why do worms need cholesterol?, Nat Cell Biol, 5, 684, 10.1038/ncb0803-684

Kniazeva, 2004, Monomethyl branched-chain fatty acids play an essential role in Caenorhabditis elegans development, PLoS Biol, 2, E257, 10.1371/journal.pbio.0020257

Xu, 1999, Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. A mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats, J Biol Chem, 274, 23577, 10.1074/jbc.274.33.23577

Worgall, 1998, Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein, J Biol Chem, 273, 25537, 10.1074/jbc.273.40.25537

Xu, 2001, Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression by accelerating transcript decay, J Biol Chem, 276, 9800, 10.1074/jbc.M008973200

Coleman, 2004, Enzymes of triacylglycerol synthesis and their regulation, Prog Lipid Res, 43, 134, 10.1016/S0163-7827(03)00051-1

Pawar, 2003, The role of liver X receptor-alpha in the fatty acid regulation of hepatic gene expression, J Biol Chem, 278, 40736, 10.1074/jbc.M307973200

Yoshikawa, 2003, Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling, Mol Endocrinol, 17, 1240, 10.1210/me.2002-0190

Zhao, 2004, Polyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targets, DNA Cell Biol, 23, 519, 10.1089/1044549041562267

Watanabe, 2004, Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c, J Clin Invest, 113, 1408, 10.1172/JCI21025

Botolin, 2006, Docosahexaneoic acid (22:6,n−3) regulates rat hepatocyte SREBP-1 nuclear abundance by Erk- and 26S proteasome-dependent pathways, J Lipid Res, 47, 181, 10.1194/jlr.M500365-JLR200

Davidson, 2006, Mechanisms for the hypotriglyceridemic effect of marine omega−3 fatty acids, Am J Cardiol, 98, 27i, 10.1016/j.amjcard.2005.12.024